Compare GEHC & ARES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | GEHC | ARES |
|---|---|---|
| Founded | 1892 | 1997 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Investment Managers |
| Sector | Technology | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 27.9B | 32.1B |
| IPO Year | 2022 | 2014 |
| Metric | GEHC | ARES |
|---|---|---|
| Price | $64.31 | $128.49 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 13 | 16 |
| Target Price | $88.38 | ★ $165.50 |
| AVG Volume (30 Days) | ★ 2.6M | 1.7M |
| Earning Date | 04-29-2026 | 05-01-2026 |
| Dividend Yield | 0.24% | ★ 4.87% |
| EPS Growth | ★ 4.84 | N/A |
| EPS | ★ 0.85 | N/A |
| Revenue | ★ $20,625,000,000.00 | $4,755,618,000.00 |
| Revenue This Year | $7.12 | N/A |
| Revenue Next Year | $4.45 | $17.59 |
| P/E Ratio | ★ $75.38 | $78.35 |
| Revenue Growth | 4.84 | ★ 28.86 |
| 52 Week Low | $58.75 | $95.80 |
| 52 Week High | $89.77 | $186.85 |
| Indicator | GEHC | ARES |
|---|---|---|
| Relative Strength Index (RSI) | 35.13 | 43.00 |
| Support Level | $60.17 | $118.91 |
| Resistance Level | $65.83 | $143.60 |
| Average True Range (ATR) | 1.48 | 4.05 |
| MACD | -1.10 | -1.70 |
| Stochastic Oscillator | 18.35 | 16.37 |
GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (45% of revenue), advanced visualization solutions (26%), patient care solutions (15%), and pharmaceutical diagnostics (14%). The company's sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 46%, 26%, 11%, and 17%, respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (about one-third of revenue), pharmaceutical diagnostics (about 10%-15%), and digital solutions (just over 5%).
Ares Management is one of the world's largest alternative-asset managers, with $622.5 billion in total assets under management, or AUM, including $384.9 billion in fee-earning AUM, at the end of 2025. The company has four main business segments: credit strategies ($406.9 billion in total AUM and $249.8 billion in fee-earning AUM), private equity, ($25.3 billion/$14.4 billion), real estate/real assets ($139.1 billion/$84.1 billion), and other alternatives ($51.2 billion/$36.6 billion). The firm primarily serves institutional investors (80% of AUM) and high-net-worth individuals (20%). Ares operates through more than 35 offices in over 15 countries around the globe.